US Patent Issued to G2GBIO on April 21 for "Pharmaceutical comprising sustained-release microspheres including GLP-1 analogue or pharmaceutically acceptable salt thereof" (South Korean Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,426, issued on April 21, was assigned to G2GBIO INC. (Daejeon, South Korea).

"Pharmaceutical comprising sustained-release microspheres including GLP-1 analogue or pharmaceutically acceptable salt thereof" was invented by Yongha Na (Daejeon, South Korea), Dongpil Won (Daejeon, South Korea), Yejin Kim (Daejeon, South Korea), Juhan Lee (Daejeon, South Korea), Heekyoung Choe (Ansan-si, South Korea), Eunyoung Seol (Sejong, South Korea) and Heeyong Lee (Daejeon, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a pharmaceutical composition useful for prevention or treatment of diabetes, beta-cell function preserv...